"HeLa Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays.
| Descriptor ID |
D006367
|
| MeSH Number(s) |
A11.251.210.190.400 A11.251.860.180.400 A11.436.340
|
| Concept/Terms |
HeLa Cells- HeLa Cells
- Cell, HeLa
- Cells, HeLa
- HeLa Cell
|
Below are MeSH descriptors whose meaning is more general than "HeLa Cells".
Below are MeSH descriptors whose meaning is more specific than "HeLa Cells".
This graph shows the total number of publications written about "HeLa Cells" by people in this website by year, and whether "HeLa Cells" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 0 | 1 | 1 |
| 1996 | 0 | 1 | 1 |
| 1997 | 1 | 3 | 4 |
| 1998 | 0 | 6 | 6 |
| 1999 | 0 | 5 | 5 |
| 2000 | 0 | 3 | 3 |
| 2001 | 0 | 5 | 5 |
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 12 | 12 |
| 2004 | 0 | 9 | 9 |
| 2005 | 0 | 9 | 9 |
| 2006 | 0 | 12 | 12 |
| 2007 | 0 | 5 | 5 |
| 2008 | 0 | 6 | 6 |
| 2009 | 0 | 4 | 4 |
| 2010 | 0 | 10 | 10 |
| 2011 | 0 | 11 | 11 |
| 2012 | 0 | 7 | 7 |
| 2013 | 0 | 13 | 13 |
| 2014 | 0 | 9 | 9 |
| 2015 | 0 | 12 | 12 |
| 2016 | 0 | 8 | 8 |
| 2017 | 0 | 5 | 5 |
| 2018 | 0 | 4 | 4 |
| 2019 | 0 | 5 | 5 |
| 2020 | 0 | 3 | 3 |
| 2021 | 0 | 7 | 7 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "HeLa Cells" by people in Profiles.
-
Restricting a-synuclein transport into mitochondria by inhibition of a-synuclein-VDAC complexation as a potential therapeutic target for Parkinson's disease treatment. Cell Mol Life Sci. 2022 Jun 19; 79(7):368.
-
Genetic fusions favor tumorigenesis through degron loss in oncogenes. Nat Commun. 2021 11 18; 12(1):6704.
-
GRASP55 regulates intra-Golgi localization of glycosylation enzymes to control glycosphingolipid biosynthesis. EMBO J. 2021 10 18; 40(20):e107766.
-
The DNA-binding protein CST associates with the cohesin complex and promotes chromosome cohesion. J Biol Chem. 2021 09; 297(3):101026.
-
Nonpeptidic, Polo-Box Domain-Targeted Inhibitors of PLK1 Block Kinase Activity, Induce Its Degradation and Target-Resistant Cells. J Med Chem. 2021 07 22; 64(14):9916-9925.
-
Centrosomal P4.1-associated protein (CPAP) positively regulates endocytic vesicular transport and lysosome targeting of EGFR. Sci Rep. 2021 06 16; 11(1):12689.
-
Golgi maturation-dependent glycoenzyme recycling controls glycosphingolipid biosynthesis and cell growth via GOLPH3. EMBO J. 2021 04 15; 40(8):e107238.
-
The doxorubicin-induced cell motility network is under the control of the ceramide-activated protein phosphatase 1 alpha. FASEB J. 2021 03; 35(3):e21396.
-
Ceramide launches an acute anti-adhesion pro-migration cell signaling program in response to chemotherapy. FASEB J. 2020 06; 34(6):7610-7630.
-
The Marine Natural Product Manzamine A Inhibits Cervical Cancer by Targeting the SIX1 Protein. J Nat Prod. 2020 02 28; 83(2):286-295.